Skip to main content

AMLX

Amylyx Pharmaceuticals, Inc.

Company with tickers: AMLX

CIK
1658551
CUSIP
03237H101
Shares Outstanding
111,186,317
13F Activity (30d)
101 filings 98 filers

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-03-02 Bedrosian Camille L 6,461
2026-03-02 Cohen Joshua B 29,282
2026-03-02 Mazzariello Gina 6,844
2026-03-02 Klee Justin B. 29,282
2026-03-02 Frates James M 7,909
2026-02-23 Mazzariello Gina 3,419
2026-02-02 Cohen Joshua B 15,500
2026-02-02 Frates James M 3,557
2026-02-02 Mazzariello Gina 3,448
2026-02-02 Klee Justin B. 15,500
2026-01-16 JOSHUA COHEN 1,974
2026-01-16 JUSTIN KLEE 1,995
2026-01-15 JUSTIN KLEE 136,193
2026-01-15 JOSHUA COHEN 136,193
2026-01-06 Frates James M 3,326
2026-01-06 Cohen Joshua B 7,715
2026-01-06 Klee Justin B. 7,715
2025-12-01 Bedrosian Camille L 6,580
2025-08-12 GINA MAZZARIELLO 30,000
2024-05-15 GINA MAZZARIELLO 10,455
2023-08-15 GINA MAZZARIELLO 6,164
2023-05-16 JAMES M FRATES 32,500
2023-05-15 PATRICK YERAMIAN 49,579
2023-04-17 Patrick D. Yeramian 49,579
2023-03-16 Justin Bernard Klee 100,000
2023-03-16 James Matthew Frates 32,500
2023-03-16 Patrick D. Yeramian 54,627
2023-03-16 Joshua Barry Cohen 100,000
2023-03-16 George Mclean Milne, Jr. 35,000
Showing 1–29 of 29 filings